INVOcell Appoints Yve Lyppens as Director Business Development Asia Pacific

SARASOTA, Fla., March 11, 2020 -- (Healthcare Sales & Marketing Network) -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced that Yve Lyppens has been... Devices, Personnel INVO Bioscience, INVO Procedure, INVOcell, Assisted Reproductive Technology
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news